Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)

NCT05188586 is registered in ClinicalTrials.gov with ClearNote Health as lead sponsor.

NCT NCT05188586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05188586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)
Lead sponsor
ClearNote Health
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2022
Completion date
March 16, 2023
Enrollment
26 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer